PE Tech Report


Like this article?

Sign up to our free newsletter

bm|t leads €10m PreciPoint Group series A funding round

Existing investors, including bm-t beteiligungsmanagement thüringen (bm|t), and a new family office, have led a €10 million series A funding round in German medtech startup PreciPoint Group, a specialist in the digitalisation of microscopy and laboratory workflows.

This financing will be used to advance the international commercialisation of the company´s first IVD medical product, market entry in the USA as well as further technological development of additional innovative solutions.   

In 2022, PreciPoint will commercially launch the iO:M8 ROSE, a solution for the digitisation of intraoperative microscopic assessments during cancer surgeries. These examinations, during which pathologists determine whether sufficient material has been removed from the patient’s body and whether the margins are free of cancer cells, are traditionally performed by specialists being bound to location and time using classic light microscopes for imaging. PreciPoint’s solutions enable entirely new ways of working, allowing significant cost savings and, most importantly, better patient care.

Like this article? Sign up to our free newsletter